Larry Liberti, PhD
Centre for Innoovation in Regulatory Sciences, Ltd.
Dr Liberti has worked in the fields of pharmaceutical regulatory affairs, communications, and clinical R&D for the past four decades. Since 2009 he has served as the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, Ltd), a part of Clarivate Analytics. He has been actively involved in promulgating best practices in the regulatory aspects of medicines development, especially in the emerging markets.
Dr Liberti received his doctorate in International Regulatory Policy through the World Health Organization (WHO) Collaborating Centre for Pharmaceutical Policy and Regulation based in the Utrecht Institute for Pharmaceutical Sciences, Utrecht University, where his research centered on expedited regulatory pathways with applicability in the emerging markets. He received both his bachelor of science in pharmacy and master’s degree in pharmacognosy from the Philadelphia College of Pharmacy and Science (now the University of the Sciences in Philadelphia). He attained the status of Regulatory Affairs Certified (RAC) with the Regulatory Affairs Professional Society and was awarded an honorary Doctor of Science degree by his alma mater. He is a Fellow of the American Medical Writers Association and is a recipient of their Golden Apple award for excellence in teaching. Dr Liberti is a co-founder of the Erudee Foundation, a non-profit dedicated to supporting local post-secondary educational opportunities for students in the Caribbean and East Africa.